Chemours is a specialty chemicals business based in the US. Chemours shares (CC) are listed on the NYSE and all prices are listed in US Dollars. Chemours employs 6,200 staff and has a trailing 12-month revenue of around $5.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $23.89 |
|---|---|
| 52-week range | $14.97 - $36.54 |
| 50-day moving average | $24.61 |
| 200-day moving average | $26.94 |
| Wall St. target price | $30.44 |
| PE ratio | N/A |
| Dividend yield | $1 (4.19%) |
| Earnings per share (TTM) | $-2.22 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $23.89 from 2024-07-25
| 1 week (2024-07-19) | 1.75% |
|---|---|
| 1 month (2024-06-27) | 3.46% |
| 3 months (2024-04-26) | -12.55% |
| 6 months (2024-01-26) | -23.65% |
| 1 year (2023-07-27) | -37.05% |
|---|---|
| 2 years (2022-07-27) | -30.19% |
| 3 years (2021-07-27) | 32.0358 |
| 5 years (2019-07-26) | 38.17% |
Valuing Chemours stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemours's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chemours's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6685. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemours's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chemours's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $869 million.
The EBITDA is a measure of a Chemours's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5.8 billion |
|---|---|
| Operating margin TTM | 8.52% |
| Gross profit TTM | $1.6 billion |
| Return on assets TTM | 4.57% |
| Return on equity TTM | -33.3% |
| Profit margin | -5.67% |
| Book value | $5.05 |
| Market Capitalization | $3.5 billion |
TTM: trailing 12 months
Dividend payout ratio: 42.37% of net profits
Recently Chemours has paid out, on average, around 42.37% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemours shareholders could enjoy a 4.19% return on their shares, in the form of dividend payments. In Chemours's case, that would currently equate to about $1 per share.
While Chemours's payout ratio might seem fairly standard, it's worth remembering that Chemours may be investing much of the rest of its net profits in future growth.
Chemours's most recent dividend payout was on 13 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 14 August 2024 (the "ex-dividend date").
Over the last 12 months, Chemours's shares have ranged in value from as little as $14.9685 up to $36.5411. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemours's is 1.794. This would suggest that Chemours's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.